Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies

Cytokine-induced killer (CIK) cells have been proved to be an effective method of tumor immunotherapy in numerous preclinical and clinical studies. In our previous study, a new method was developed to prime and propagate CIK cells by the combination of IL-2 and IL-15, and this kind of CIK cells had...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Wang, Run-Qing, Zhong, Yi-Ming, Meng, Ming-Yao, Zhao, Yi-Yi, Yang, Li-Rong, Li, Lin, Hou, Zong-Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443387/
https://www.ncbi.nlm.nih.gov/pubmed/34540187
http://dx.doi.org/10.1155/2021/5709104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443387/
https://www.ncbi.nlm.nih.gov/pubmed/34540187
http://dx.doi.org/10.1155/2021/5709104

Ejemplares similares